,NR 566 Midterm Exam | Advanced Pharmacology for Care of
the Family (2026) Actual Q&A PDF | Chamberlain
1. Which pharmacokinetic process describes the movement of a medication from the
gastrointestinal tract into systemic circulation?
A) Distribution
B) Absorption
C) Metabolism
D) Excretion
Correct Answer: Absorption
Rationale: Absorption is the movement of a drug from its site of administration into
the systemic circulation. Oral medications must first dissolve and cross gastrointestinal
membranes before entering the bloodstream. Distribution occurs after systemic
absorption, whereas metabolism and excretion contribute to elimination.
2. Which pharmacokinetic parameter describes the proportion of an administered drug
dose that reaches systemic circulation unchanged?
A) Half-life
B) Clearance
C) Bioavailability
D) Volume of distribution
,Correct Answer: Bioavailability
Rationale: Bioavailability represents the fraction of an administered dose that reaches
systemic circulation in active form. Intravenous administration has essentially complete
bioavailability, whereas oral administration may have reduced bioavailability because of
incomplete absorption and first-pass metabolism.
3. A medication with a narrow therapeutic index requires particular attention to which
principle?
A) Minimal monitoring is necessary
B) Small changes in concentration may cause toxicity or treatment failure
C) The medication can be given at any dose
D) Therapeutic drug monitoring is never useful
Correct Answer: Small changes in concentration may cause toxicity or treatment
failure
Rationale: A narrow therapeutic index means that the effective concentration is
relatively close to the toxic concentration. Drugs in this category may require serum-
level monitoring, careful dose adjustment, and assessment for drug interactions.
4. Which organ is primarily responsible for metabolism of many medications?
A) Liver
, B) Spleen
C) Pancreas
D) Thyroid
Correct Answer: Liver
Rationale: The liver contains numerous metabolic enzymes, including cytochrome
P450 enzymes, that transform many medications into metabolites. Hepatic impairment
can therefore alter drug exposure and may require dose or medication selection
adjustments.
5. What is the principal purpose of a loading dose?
A) To permanently increase renal clearance
B) To rapidly achieve a desired therapeutic concentration
C) To eliminate adverse effects
D) To prevent absorption
Correct Answer: To rapidly achieve a desired therapeutic concentration
Rationale: A loading dose is used when rapid achievement of therapeutic drug
concentrations is clinically desirable. The appropriate loading dose depends
substantially on the medication's volume of distribution and the target concentration.
6. Which statement best describes pharmacodynamics?
the Family (2026) Actual Q&A PDF | Chamberlain
1. Which pharmacokinetic process describes the movement of a medication from the
gastrointestinal tract into systemic circulation?
A) Distribution
B) Absorption
C) Metabolism
D) Excretion
Correct Answer: Absorption
Rationale: Absorption is the movement of a drug from its site of administration into
the systemic circulation. Oral medications must first dissolve and cross gastrointestinal
membranes before entering the bloodstream. Distribution occurs after systemic
absorption, whereas metabolism and excretion contribute to elimination.
2. Which pharmacokinetic parameter describes the proportion of an administered drug
dose that reaches systemic circulation unchanged?
A) Half-life
B) Clearance
C) Bioavailability
D) Volume of distribution
,Correct Answer: Bioavailability
Rationale: Bioavailability represents the fraction of an administered dose that reaches
systemic circulation in active form. Intravenous administration has essentially complete
bioavailability, whereas oral administration may have reduced bioavailability because of
incomplete absorption and first-pass metabolism.
3. A medication with a narrow therapeutic index requires particular attention to which
principle?
A) Minimal monitoring is necessary
B) Small changes in concentration may cause toxicity or treatment failure
C) The medication can be given at any dose
D) Therapeutic drug monitoring is never useful
Correct Answer: Small changes in concentration may cause toxicity or treatment
failure
Rationale: A narrow therapeutic index means that the effective concentration is
relatively close to the toxic concentration. Drugs in this category may require serum-
level monitoring, careful dose adjustment, and assessment for drug interactions.
4. Which organ is primarily responsible for metabolism of many medications?
A) Liver
, B) Spleen
C) Pancreas
D) Thyroid
Correct Answer: Liver
Rationale: The liver contains numerous metabolic enzymes, including cytochrome
P450 enzymes, that transform many medications into metabolites. Hepatic impairment
can therefore alter drug exposure and may require dose or medication selection
adjustments.
5. What is the principal purpose of a loading dose?
A) To permanently increase renal clearance
B) To rapidly achieve a desired therapeutic concentration
C) To eliminate adverse effects
D) To prevent absorption
Correct Answer: To rapidly achieve a desired therapeutic concentration
Rationale: A loading dose is used when rapid achievement of therapeutic drug
concentrations is clinically desirable. The appropriate loading dose depends
substantially on the medication's volume of distribution and the target concentration.
6. Which statement best describes pharmacodynamics?
